Performance evaluation of four 25-hydroxyvitamin D assays to measure 25-hydroxyvitamin D2

Clinical Biochemistry

Volumn 48, Issue 16-17, 2015, Pages 1097-1104

  Freeman, James ^a   Wilson, Kimberly ^a   Spears, Ryan ^a   Shalhoub, Victoria ^a   Sibley, Paul ^a  

^a Siemens Healthcare Diagnostics Inc   (United States)

Author keywords

25 Hydroxyvitamin D; 25(OH)D; 25(OH)D2; 25(OH)D3; ID LC MS MS; VDSCP; Vitamin D; Vitamin D total assay

Indexed keywords

25 HYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CERTIFICATION; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPH; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; VITAMIN BLOOD LEVEL; VITAMIN D TOTAL IMMUNOASSAY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BIOASSAY; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DIETARY SUPPLEMENT; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; STANDARD; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

25-HYDROXYVITAMIN D 2; ADULT; AGED; BIOLOGICAL ASSAY; CHROMATOGRAPHY, LIQUID; DIETARY SUPPLEMENTS; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; VITAMIN D; YOUNG ADULT;

EID: 84947023687     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.05.021     Document Type: Article

References (51)

1. Holick M.F. Vitamin D, deficiency. N Engl J Med 2007, 357:266-281.
2. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
3. Holick M.F., Chen T.C., Lu Z., Sauter E. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res 2007, 22(Suppl. 2):V28-V33.
4. Heaney R.P., Barger-Lux M.J., Dowell M.S., Chen T.C., Holick M.F. Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 1997, 82:4111-4116.
5. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60y. Am J Clin Nutr 2004, 80:752-758.
6. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80:1689s-1696s.
7. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326:469.
8. Armas L.A., Hollis B.W., Heaney R.P. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004, 89:5387-5391.
9. Biancuzzo R.M., Young A., Bibuld D., et al. Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr 2010, 91:1621-1626.
10. Binkley N., Gemar D., Engelke J., et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600IU daily or 50,000IU monthly in older adults. J Clin Endocrinol Metab 2011, 96:981-988.
11. Clemens T.L., Zhou X.Y., Myles M., Endres D., Lindsay R. Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects. J Clin Endocrinol Metab 1986, 63:656-660.
12. Heaney R.P., Davies K.M., Chen T.C., Holick M.F., Barger-Lux M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003, 77:204-210.
13. Holick M.F., Biancuzzo R.M., Chen T.C., et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008, 93:677-681.
14. Malabanan A., Veronikis I.E., Holick M.F. Redefining vitamin D insufficiency. Lancet 1998, 351:805-806.
15. Vieth R. Vitamin D, supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999, 69:842-856.
16. Vieth R., Chan P.C., MacFarlane G.D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001, 73:288-294.
17. Adams J.S., Kantorovich V., Wu C., Javanbakht M., Hollis B.W. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab 1999, 84:2729-2730.
18. Bischoff-Ferrari H.A., Shao A., Dawson-Hughes B., Hathcock J., Giovannucci E., Willett W.C. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 2010, 21:1121-1132.
19. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009, 169:551-561.
20. Heaney R.P., Recker R.R., Grote J., Horst R.L., Armas L.A. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 2011, 96:E447-E452.
21. Houghton L.A., Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006, 84:694-697.
22. Leventis P., Kiely P.D. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 2009, 38:149-153.
23. Logan V.F., Gray A.R., Peddie M.C., Harper M.J., Houghton L.A. Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months. Br J Nutr 2013, 109:1082-1088.
24. Romagnoli E., Mascia M.L., Cipriani C., et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 2008, 93:3015-3020.
25. Trang H.M., Cole D.E., Rubin L.A., Pierratos A., Siu S., Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998, 68:854-858.
26. Tripkovic L., Lambert H., Hart K., et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 2012, 95:1357-1364.
27. Stephensen C.B., Zerofsky M., Burnett D.J., et al. Ergocalciferol from mushrooms or supplements consumed with a standard meal increases 25-hydroxyergocalciferol but decreases 25-hydroxycholecalciferol in the serum of healthy adults. J Nutr 2012, 142:1246-1252.
28. Thienpont L.M., Stepman H.C., Vesper H.W. Standardization of measurements of 25-hydroxyvitamin D3 and D2. Scand J Clin Lab Invest Suppl 2012, 243:41-49.
29. Farrell C., Soldo J., Williams P., Herrmann M. 25-Hydroxyvitamin D testing: challenging the performance of current automated immunoassays. Clin Chem Lab Med 2012, 50:1953-1963.
30. Holmes E.W., Garbincius J., McKenna K.M. Analytical variability among methods for the measurement of 25-hydroxyvitamin D: still adding to the noise. Am J Clin Pathol 2013, 140:550-560.
31. Hsu S.A., Soldo J., Gupta M. Evaluation of two automated immunoassays for 25-OH vitamin D: comparison against LC-MS/MS. J Steroid Biochem Mol Biol 2013, 136:139-145.
32. Le Goff C., Peeters S., Crine Y., Lukas P., Souberbielle J.C., Cavalier E. Evaluation of the cross-reactivity of 25-hydroxyvitamin D2 on seven commercial immunoassays on native samples. Clin Chem Lab Med 2012, 50:2031-2032.
33. Moon H.W., Cho J.H., Hur M., et al. Comparison of four current 25-hydroxyvitamin D assays. Clin Biochem 2012, 45:326-330.
34. Siemens ADVIA Centaur®, ADVIA Centaur® XP Vitamin D Total (VitD) Assay [directional insert 10699279_EN Rev. A, 2013-07] 2013, Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA.
35. DiaSorin LIAISON® 25 OH Vitamin D TOTAL Assay [directional insert] DiaSorin, Stillwater, MN, USA 2012.
36. Abbott ARCHITECT® 25-OH Vitamin D Assay [directional insert 3L52, G2-3231/R03] 2011, Abbott Laboratories, Abbott Park, IL, USA.
37. Roche ELECSYS® Vitamin D total assay [directional insert 06506780 160] 2013-07, 3.0. Roche Diagnostics GmbH, Sandhofer Strasse 116, D-68305 Mannheim, Germany.
38. Miller W.G., Myers G.L., Gantzer M.L., et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011, 57:1108-1117.
39. Sempos C.T., Vesper H.W., Phinney K.W., Thienpont L.M., Coates P.M. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl 2012, 243:32-40.
40. Stepman H.C., Vanderroost A., Van Uytfanghe K., Thienpont L.M. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 2011, 57:441-448.
41. Clinical and Laboratory Standards Institute (formerly NCCLS) Evaluation of precision performance of quantitative measurement methods: approved guideline 2004, Clinical and Laboratory Standards Institute, Wayne, PA, [NCCLS Document EP5-A2].
42. Farrell C.J., Martin S., McWhinney B., Straub I., Williams P., Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 2012, 58:531-542.
43. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
44. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005, 16:713-716.
45. Pepe J., Romagnoli E., Nofroni I., et al. Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int 2005, 16:805-812.
46. Aloia J.F., Patel M., Dimaano R., et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 2008, 87:1952-1958.
47. MacDonald H.M., Wood A.D., Tang J.C., Fraser W.D. Comparison of vitamin D(2) and vitamin D(3) supplementation in increasing serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 2012, 96:1152-1153. [author reply 3-4].
48. Glendenning P., Chew G.T., Seymour H.M., et al. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 2009, 45:870-875.
49. Tjellesen L., Hummer L., Christiansen C., Rodbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner 1986, 1:407-413.
50. Hollis B.W. Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. J Steroid Biochem 1984, 21:81-86.
51. Freeman J., Wilson K., Spears R., Shalhoub V., Sibley P. Influence of vitamin D binding protein on accuracy of 25-hydroxyvitamin D measurement using the ADVIA centaur vitamin D total assay. Int J Endocrinol 2014, 2014. Article ID 691679. 10.1155/2014/691679.